Combined chemotherapy (CT) and erlotinib (E) as a first-line treatment of EGFR-mutated (EGFR M) NSCLC.

e19076 Background: EGFR-TKI's and CT induce apoptosis in EGFR M NSCLC by different mechanisms that may result in synergistic effects when used concurrently rather than sequentially. We reviewed the...